Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Krystal Biotech, Inc. KRYS

Set alert

Price alert · KRYS

All alert types
302.93 USD +7.03 +2.38%

As of Nov 3, 12:13 PM ET

Bid
302.62 × 1
Ask
303.00 × 1
293.26 Day range 305.43
192.52 52-week range 382.54
YTD
+22.87%
1 year
+53.11%
Open
293.49
Prev close
295.90
Mkt cap
8.97B
Vol
185.53K
Avg vol
272.85K
EPS
7.36
P/E
41.15
Div yield
0.00%
More statistics
Low
293.26
High
305.43
Forward P/E
33.03
Beta
0.65
Short ratio
9.85
Inst. own
104.39%
Dividend
0.00
Ex-div date
Earnings
Feb 16, 2027
50-d avg
337.46
200-d avg
308.53
1y target
395.44

1D chart

Chart tools
Interval
1m5m15m30m

Signals (38)
NameTimeAgo
SMA: Bullish12:03 PM10 minutes ago
SMA: Bearish12:02 PM11 minutes ago
MACD: Sell Signal12:01 PM12 minutes ago
RSI: Overbought11:54 AM19 minutes ago
RSI: Overbought11:49 AM24 minutes ago
SMA: Bullish11:40 AM33 minutes ago
SMA: Bullish11:40 AM33 minutes ago
SMA: Bearish11:39 AM34 minutes ago
SMA: Bearish11:39 AM34 minutes ago
SMA: Bullish11:37 AM36 minutes ago
SMA: Bullish11:37 AM36 minutes ago
MACD: Buy Signal11:34 AM39 minutes ago
SMA: Bearish11:29 AM44 minutes ago
MACD: Sell Signal11:29 AM44 minutes ago
MACD: Buy Signal11:28 AM45 minutes ago
SMA: Bullish11:27 AM46 minutes ago
SMA: Bearish11:22 AM51 minutes ago
MACD: Sell Signal11:22 AM51 minutes ago
SMA: Bullish11:11 AM1 hour ago
MACD: Buy Signal10:59 AM1 hour ago

Newest 20 of 38.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 395.44 +30.5% upside
Target (low)
284.00
Target (mean)
395.44
Target (high)
474.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy10
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 12
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KRYS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.921.49 – 3.042.66-27.9%126.54M+29.4%10
Next quarter2.011.69 – 3.121.70+18.4%134.28M+25.4%10
Current year7.596.77 – 10.266.84+10.9%496.69M+27.6%11
Next year8.956.47 – 11.977.59+18.0%634.23M+27.7%11

Upgrades and downgrades

The latest rating changes

KRYS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 21, 2026B of A SecuritiesMaintainedBuyBuy
Aug 14, 2026RBC CapitalInitiated—Outperform
Aug 4, 2026CitigroupMaintainedBuyBuy
Jul 14, 2026B of A SecuritiesMaintainedBuyBuy
Jun 18, 2026TD CowenMaintainedBuyBuy
Jun 16, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 1, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 22, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 18, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 5, 2026CitigroupMaintainedBuyBuy
May 5, 2026Evercore ISI GroupMaintainedOutperformOutperform
May 4, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 27, 2026Wolfe ResearchInitiated—Peer Perform
Feb 25, 2026GuggenheimMaintainedBuyBuy
Feb 18, 2026CitigroupMaintainedBuyBuy
Feb 18, 2026Chardan CapitalMaintainedBuyBuy
Feb 17, 2026JefferiesMaintainedBuyBuy
Feb 2, 2026Goldman SachsMaintainedBuyBuy
Jan 22, 2026B of A SecuritiesMaintainedBuyBuy
Jan 12, 2026CitigroupMaintainedBuyBuy
Jan 9, 2026TD CowenMaintainedBuyBuy
Jan 9, 2026CitigroupMaintainedBuyBuy
Jan 9, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 6, 2026CitigroupUpgradeNeutralBuy
Nov 4, 2025CitigroupMaintainedNeutralNeutral
Nov 4, 2025Chardan CapitalMaintainedBuyBuy
Oct 17, 2025B of A SecuritiesMaintainedBuyBuy
Sep 15, 2025HC Wainwright & Co.ReiteratedBuyBuy
Aug 22, 2025Chardan CapitalMaintainedBuyBuy